Comparison of a pharmacist-managed lipid clinic: In-person versus telephone

Journal of the American Pharmacists Association

Volumn 50, Issue 3, 2010, Pages 375-378

  Dolder, Nicole M ^a   Dolder, Christian R ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WINGATE UNIVERSITY   (United States)

^c CAROLINAS MEDICAL CENTER   (United States)

Author keywords

Dyslipidemias; Outpatient setting; Pharmacists; Pharmacotherapy; Telephone interventions

Indexed keywords

ANTILIPEMIC AGENT; LIPID;

AGED; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; FEMALE; GOVERNMENT; HEALTH CARE DELIVERY; HUMAN; HYPERLIPIDEMIA; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; PHARMACIST; RETROSPECTIVE STUDY; TELEPHONE; UNITED STATES;

AGED; AMBULATORY CARE FACILITIES; ANTILIPEMIC AGENTS; CORONARY ARTERY DISEASE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYPERLIPIDEMIAS; LIPIDS; MALE; MIDDLE AGED; PHARMACISTS; RETROSPECTIVE STUDIES; TELEPHONE; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 77955290293     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2010.09048     Document Type: Article

References (10)

1. National Center for Chronic Disease Prevention and Health Promotion. Heart disease and stroke prevention: addressing the nation's leading killers. Accessed at www.cdc.gov/nccdphp/publications/AAG/pdf/dhdsp.pdf, March 27, 2009.
2. American Heart Association, American Stroke Association. Heart disease and stroke statistics. Accessed at www.american-heart.org/downloadable/heart/ 1200082005246HS-Stats%202008.final.pdf, December 3, 2008.
3. Collins C, Kramer A, O'Day ME, Low MB. Evaluations of patient and provider satisfaction with a pharmacist-managed lipid clinic in a Veterans Affairs medical center. Am J Health Syst Pharm. 2006;63:1723-7.
4. Holsclaw SL, Olson KL, Hornak R, Denham AM. Assessment of patient satisfaction with telephone and mail interventions provided by a clinical pharmacy cardiac risk reduction service. J Manag Care Pharm. 2005;11:403-9.
5. Mazzolini TA, Irons BK, Schell EC, Seifert CF. Lipid levels and use of lipid-lowering drugs in pharmacist-managed lipid clinics versus usual care in 2 VA Medical Centers. J Manag Care Pharm. 2005;11:763-71.
6. Bunting BA, Smith BH, Sutherland SE. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48:23-31.
7. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in Project ImPACT: Hyperlipidemia. J Am Pharm Assoc. 2000;40:157-65.
8. Bozovich M, Rubino CM, Edmunds J. Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals. Pharmacotherapy. 2000;20:1375-83.
9. Ito MK. Role of the pharmacist in establishing lipid intervention programs. Pharmacotherapy. 2003;23:41-7S.
10. National Institutes of Health. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Accessed at www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf, August 5, 2009.